Delivery Order SPE2DB22D1106-SPE2DB25FERB6
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,572.68 by the Defense Logistics Agency for the supply of Rabavert rabies vaccine with diluents. The contract, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a firm fixed-price procurement with no set-aside designation. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,008.95 on October 16, 2025, for the supply of Rabavert rabies vaccine with diluents. This firm fixed price, non-set-aside contract is funded by the Defense Logistics Agency's Medical Supply Chain and carries an ultimate completion date of October 17, 2025. The order will be fulfilled at AmerisourceBergen's Conshohocken facility and represents a...
- The Defense Logistics Agency awarded a $5,239.50 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal procurement relationships,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $40,441.62 for Rabavert rabies vaccine with diluents under a firm fixed-price contract. This non-set-aside award, issued on July 29, 2025, represents a child order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The vaccine will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency for Rabavert rabies vaccine with diluents valued at $3,246.40. This competitively awarded, firm fixed-price delivery order, with no set-aside designation, was issued on November 25, 2025, with an ultimate completion date of November 26, 2025. The contract represents a small-value transaction for critical medical supplies supporting federal healthcare...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain for Rabavert rabies vaccine with diluents. The contract, awarded on October 28, 2025, carries a ceiling value of $1,257.48 under firm fixed pricing with an ultimate completion date of October 29, 2025. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $41,916 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger contract vehicle supporting federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 16, 2025, for the supply of Rabavert rabies vaccine with diluents. This firm fixed price delivery order, valued at $62,874.00, is scheduled for completion by July 17, 2025, and represents a non-set-aside competitive award. The contract will be performed at the company's corporate office location in Conshohocken,...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $10,479.00 to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Rabavert rabies vaccine with diluents. This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of September 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive role as a critical...
- The Defense Logistics Agency awarded a $30,134.91 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This is a firm fixed-price, non-set-aside contract with a completion date of April 9, 2025, issued on April 8, 2025. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a tactical procurement fulfilling immediate medical supply needs within...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FERB6Delivery Order
AmerisourceBergen Drug Corp was awarded a $41,916 firm fixed price delivery order by the Defense Logistics Agency (DLA) for Rabavert rabies vaccine with diluents, with an ultimate completion date of June 3, 2025. The non-set-aside, competitively awarded contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio and aligns with the company's extensive role as a critical medical vendor supporting military and veteran healthcare systems. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and other critical medical commodities. The DLA Troop Support is planning next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen to continue serving defense healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.9k | 6/2/25 |